Bioganix (Holdings) Ltd Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 12106633

Bioganix (Holdings) Ltd

Filleted Unaudited Financial Statements

For the period ended

5 April 2025

Bioganix (Holdings) Ltd

Statement of Financial Position

5 April 2025

	5 Apr 25		31 Mar 24
Note	£	£	£	£

Fixed assets

Tangible assets	4	4,871,252	3,264,332
Investments	5	10,580	10,580
		------------	------------
		4,881,832	3,274,912

Current assets

Debtors	6	1,838,157	891,997
Cash at bank and in hand		756,295	1,440,530
		------------	------------
		2,594,452	2,332,527

Creditors: amounts falling due within one year	7	( 256,929)		( 328,176)
		------------		------------
Net current assets			2,337,523		2,004,351
			------------		------------
Total assets less current liabilities			7,219,355		5,279,263

Creditors: amounts falling due after more than one year	8		( 3,092,163)		( 3,116,756)

Provisions	( 647,310)	( 266,327)
	------------	------------
Net assets	3,479,882	1,896,180
	------------	------------

Capital and reserves

Called up share capital	10,000	10,000
Revaluation reserve	2,117,609	974,752
Profit and loss account	1,352,273	911,428
	------------	------------
Shareholders funds	3,479,882	1,896,180
	------------	------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

For the period ending 5 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Bioganix (Holdings) Ltd

Statement of Financial Position (continued)

5 April 2025

These financial statements were approved by the board of directors and authorised for issue on 30 December 2025 , and are signed on behalf of the board by:

Mr L M Dodds

Director

Company registration number: 12106633

Bioganix (Holdings) Ltd

Notes to the Financial Statements

Period from 1 April 2024 to 5 April 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Bonby Lane, Bonby, Brigg, North Lincolnshire, DN20 0PJ.

2. Statement of compliance

These financial statements have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

(a) Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

(b) Going concern

The UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it, and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.

(c) Consolidation

The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.

(d) Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. Revenue from the sale of electricity is recognised when the commodity is delivered on the basis of the agreed volumes and rates within the sales contracts. Income from rents receivable is recognised in accordance with the agreed terms of the relevant lease agreement.

(e) Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively . Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted at the reporting date . Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

(f) Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

(g) Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Plant and machinery	-	10% straight line

(h) Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

(i) Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.

(j) Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Tangible assets

	Freehold property	Plant and machinery	Total
	£	£	£
Cost or valuation
At 1 April 2024	3,252,318	13,920	3,266,238
Additions	92,419	–	92,419
Revaluations	1,515,894	–	1,515,894
	------------	--------	------------
At 5 April 2025	4,860,631	13,920	4,874,551
	------------	--------	------------
Depreciation
At 1 April 2024	–	1,906	1,906
Charge for the period	–	1,393	1,393
	------------	--------	------------
At 5 April 2025	–	3,299	3,299
	------------	--------	------------
Carrying amount
At 5 April 2025	4,860,631	10,621	4,871,252
	------------	--------	------------
At 31 March 2024	3,252,318	12,014	3,264,332
	------------	--------	------------

5. Investments

	Shares in group undertakings	Shares in participating interests	Total
	£	£	£
Cost
At 1 April 2024 and 5 April 2025	10,080	500	10,580
	--------	----	--------
Impairment
At 1 April 2024 and 5 April 2025	–	–	–
	--------	----	--------

Carrying amount
At 5 April 2025	10,080	500	10,580
	--------	----	--------
At 31 March 2024	10,080	500	10,580
	--------	----	--------

6. Debtors

	5 Apr 25	31 Mar 24
	£	£
Trade debtors	34,388	56,451
Amounts owed by group undertakings	1,803,353	825,103
Other debtors	416	10,443
	------------	---------
	1,838,157	891,997
	------------	---------

The debtors above include the following amounts falling due after more than one year:

	5 Apr 25	31 Mar 24
	£	£
Amounts owed by group undertakings	1,803,353	825,103
	------------	---------

7. Creditors: amounts falling due within one year

	5 Apr 25	31 Mar 24
	£	£
Bank loans	31,393	30,377
Trade creditors	2,040	–
Social security and other taxes	12,441	10,876
Other creditors	211,055	286,923
	---------	---------
	256,929	328,176
	---------	---------

The bank borrowings are secured on the assets of the company .

8. Creditors: amounts falling due after more than one year

	5 Apr 25	31 Mar 24
	£	£
Bank loans	400,538	425,131
Other creditors	2,691,625	2,691,625
	------------	------------
	3,092,163	3,116,756
	------------	------------

Included within creditors: amounts falling due after more than one year is an amount of £264,000 (2024: £293,000) in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.

The bank borrowings are secured on the assets of the company.

9. Related party transactions

The company has taken advantage of the exemptions provided in FRS 102 from reporting transactions between wholly owned members of the group. The directors and shareholders have made loans to the company. At the balance sheet date the total amounts owed to the directors and shareholders was £ 2,691,625 (2024 - £ 2,691,625 ). No interest was charged on the loans in the year. Of the loans outstanding, £nil is repayable before 31 March 2026.